OncoMatch/Clinical Trials/NCT07893327
Evaluation of the Effect of Regular Physical Exercise in Breast Cancer.
Official title: Evaluation of the Effect of Regular Physical Exercise in Women With Breast Cancer Undergoing Adjuvant Hormonal Therapy.
Is NCT07893327 recruiting? Yes, currently enrolling (Oct 2026). This NA trial studies non-drug interventions for breast cancer early stage breast cancer (stage 1-3).
This study, titled "Evaluation of the effect of regular physical exercise in women with breast cancer on adjuvant hormone therapy," is a research project designed to see how guided exercise can help women recovering from breast cancer. Here is a simple summary of the study: Who is it for? The study includes 150 women who have finished their primary treatments (like surgery or chemotherapy) and are in the early stages of hormone therapy. The Goal: Researchers want to understand how regular exercise improves quality of life, physical fitness, and nutrition. They are also studying how exercise affects the immune system and the gut microbiota (the healthy bacteria in your body). The Exercise Program: Participants take part in a 16-week supervised program. It consists of two sessions per week: one in a gym and one in a swimming pool. These sessions are led by experts and are specifically adapted to each patient's physical condition and needs. Using Technology: To help with the study, participants use a mobile app (IALIBIRD) and a wearable activity tracker (like a bracelet). These tools monitor daily steps, sleep quality, and heart rate, and allow patients to report how they feel. Medical Check-ups: Throughout the study, patients have regular visits to the hospital for blood tests and to provide saliva and stool samples for biological analysis. They also have body scans (DXA) to measure bone health, muscle mass, and body fat. Why is this important? While hormone therapy is a vital treatment, it can last for 5 to 10 years and cause side effects like extreme tiredness, joint pain, and anxiety. This study aims to prove that regular exercise is a safe and effective way to reduce these symptoms and help women feel better during their recovery.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Disease stage
Required: Stage I, II, III
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Must have received: primary oncological treatment (surgery, chemotherapy, and/or radiotherapy)
Must have completed primary oncological treatment (surgery, chemotherapy, and/or radiotherapy)
Must have received: adjuvant hormone therapy (tamoxifen, aromatase inhibitor)
within the first three months of starting adjuvant hormone therapy (tamoxifen or aromatase inhibitors)
Lab requirements
Blood counts
hemoglobin >= 10 g/dl; platelet count >= 50,000
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07893327 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received primary oncological treatment (surgery, chemotherapy, and/or radiotherapy) and adjuvant hormone therapy.
What disease stage is eligible?
Stage I or II or III is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages